Mualliflar

  • Djurabayeva M.X.
  • Allamuratova D.A.

##semicolon##

MDR-TB (multi-drug resistant tuberculosis), sil kasalligi, geterorezistentlik, dori vositalariga chidamlilik, Oxford Nanopore, Illumina, yangi avlod maqsadli sekvensiyalash (tNGS), diagnostik texnologiyalarni joriy etish, resurslari cheklangan mamlakatlar.

##submission.citations##

1. Zhdanova S., Heysell S. K., Ogarkov O., et al. Genomic epidemiology and drug resistance molecular markers of Mycobacterium tuberculosis in the Irkutsk region, Russia, and neighboring countries of the CIS // Infection, Genetics and Evolution. – 2024. – Vol. 118. – Article 105552.

2. Kozhamkulov U., Akhmetova G., Ismailov B., Tuleuova A. Multidrug resistant tuberculosis in Central Asia: epidemiology, diagnostic and treatment challenges in Uzbekistan and neighbouring countries // Antibiotics. – 2025. – Vol. 14(7). – P. 673.

3. Kayukova S. I., Vasilyeva I. A., Sterlikov S. A., et al. Tuberculosis in the post-pandemic period: epidemiological trends and challenges for the health systems of the CIS countries // Public Health and Healthcare. – 2025. – Vol. 12(1). – P. 14–29.

4. Skrahina A., Hurevich H., Zalutskaya A., et al. Drug-resistant tuberculosis in Eastern Europe and Central Asia // International Journal of Tuberculosis and Lung Disease. – 2019. – Vol. 23(10). – P. 1083–1091.

5. Skrahina A., Hurevich H., Zalutskaya A., et al. Treatment outcomes for drug-susceptible and multidrug-resistant tuberculosis in Uzbekistan // International Journal of Tuberculosis and Lung Disease. – 2022. – Vol. 26(6). – P. 545–554.

6. Mokrousov I., Vyazovaya A., Sinkov V., et al. Evolution and global spread of the Mycobacterium tuberculosis Beijing lineage: focus on the Commonwealth of Independent States (CIS) // Emerging Microbes & Infections. – 2024. – Vol. 13(1). – Article 2304512.

7. Kadura S., et al. Genomic surveillance of Mycobacterium tuberculosis resistance to new and repurposed drugs // The Lancet Microbe. – 2024. – Vol. 5(3). – P. e241–e252.

8. Nikolayevskyy V., Ismail N., Holme A., et al. Targeted next-generation sequencing for drug-resistant tuberculosis: a multi-centre study // Journal of Clinical Microbiology. – 2021. – Vol. 59, № 1. – P. e01815-20.

9. Cabibbe A. M., et al. Nanopore-based targeted sequencing test for direct tuberculosis identification, genotyping, and detection of drug resistance mutations: a side-by-side comparison of targeted next-generation sequencing technologies // Journal of Clinical Microbiology. – 2024. – Vol. 62(10). – P. e00815-24.

10. Mardis E.R. DNA sequencing technologies: 2006–2016. Nature Protocols. – 2017. – Vol. 12(2). – P. 213–218. doi:10.1038/nprot.2016.182

11. CDC NGS Quality Initiative Work Group. The Next Generation Sequencing Quality Initiative: framework for implementing NGS in clinical and public health laboratories // Centers for Disease Control and Prevention (CDC). – 2024. – Vol. 1. – P. 1–42.

12. Operario D.J., et al. Heteroresistance in Mycobacterium tuberculosis: explanations, diagnosis, and clinical implications // Clinical Microbiology Reviews. – 2018. – Vol. 31, № 4. – P. e00038-18.

13. Chen Z., Lee H., Smith R., Gupta A. Decoding the WHO Global Tuberculosis Report 2024: epidemiology and implications for global public health // Zoonoses and Public Health. – 2025. – Vol. 72. – P. 45–58.

14. Coll F., McNerney R., Guerra-Assunção J.A., et al. A robust SNP barcode for typing Mycobacterium tuberculosis complex strains // Nature Communications. – 2014. – Vol. 5. – P. 4812.

15. Cook V.J., Dheda K., Masur H., et al. Sensitive diagnosis of paucibacillary tuberculosis with targeted next-generation sequencing: a molecular diagnostic study // BMC Medicine. – 2025. – Vol. 23. – No. 128.

16. Mehaffy C., et al. Clinical impact of subclonal drug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis // The Lancet Microbe. – 2024. – Vol. 5, № 8. – P. e742–e753.

17. Papaventsis D., Casali N., Kontsevaya I., et al. Whole-genome sequencing versus targeted next-generation sequencing of Mycobacterium tuberculosis: an individual isolate and sample-level diagnostic meta-analysis // The Lancet Infectious Diseases. – 2021. – Vol. 21, № 10. – P. 1445–1455.

18. de Araujo L., Tang Y.-W., Denkinger C., et al. Implementation of targeted next-generation sequencing for the diagnosis of drug-resistant tuberculosis in low-resource settings // Frontiers in Public Health. – 2023. – Vol. 11. – Article 1204064.

19. de Nooy A.E., Shrestha S., Addae A., et al. Cost-effectiveness of targeted next-generation sequencing for tuberculosis drug-resistance testing // Clinical Infectious Diseases. – 2026. – Vol. 82(1). – P. e119–e128.

20. Nguyen T. N. A., Anton Le Berre V., Bañuls A. L., Nguyen T. V. A. Molecular Diagnosis of Drug Resistant Tuberculosis: A Literature Review // Frontiers in Microbiology. – 2019. – Vol. 10. – Article 794.

21. Ismail N., Nimmo C., Allix-Béguec C., et al. Diagnostic accuracy of targeted next-generation sequencing for the detection of drug-resistant tuberculosis: a multicentre, retrospective study // The Lancet Microbe. – 2023. – Vol. 4(12). – P. e1001–e1011.

22. Farnia P., Velayati A.A., Ghanavi J., Farnia P. Tuberculosis: An Ongoing Global Threat // Advances in Experimental Medicine and Biology. – 2026. – Vol. 1484. – P. 1–31.

23. Ghajavand P.V., Varghese D., Ismail S., et al. Application of next-generation sequencing for diagnosis and clinical management of drug-resistant tuberculosis // Frontiers in Microbiology. – 2022. – Vol. 13. – Article 775030.

24. Goodwin S., McPherson J.D., McCombie W.R. Coming of age: ten years of next-generation sequencing technologies // Nature Reviews Genetics. – 2016. – Vol. 17(6). – P. 333–351.

25. Jung S. Targeted Next-Generation Sequencing in Drug-Resistant Tuberculosis: WHO Guidance and Practical Implementation Priorities // Biomedicines. – 2026. – Vol. 14(1). – P. 93.

26. Shrestha S., Addae A., Miller C., Ismail N., Zwerling A. Cost effectiveness of targeted next generation sequencing (tNGS) for detection of tuberculosis drug resistance in India, South Africa and Georgia: a modeling analysis // eClinicalMedicine. – 2024. – Vol. 79. – P. 103003.

27. Klepac-Ceraj V., Smits S.A., Owens S.M., et al. Understanding and overcoming the pitfalls and biases of next-generation sequencing methods // European Journal of Clinical Microbiology & Infectious Diseases. – 2019. – Vol. 38(9). – P. 1583–1593.

28. Chen Y., et al. Nanopore sequencing for precise detection of Mycobacterium tuberculosis and drug resistance: a retrospective multicenter study in China // Journal of Clinical Microbiology. – 2025. – Vol. 63, № 4. – P. e01813-24.

29. Mboowa G. Reimagining tuberculosis control in the era of genomics // Pathogens. – 2025. – Vol. 14(10):975.